Innate immunity and early liver inflammation
- PMID: 37205101
- PMCID: PMC10187146
- DOI: 10.3389/fimmu.2023.1175147
Innate immunity and early liver inflammation
Abstract
The innate system constitutes a first-line defence mechanism against pathogens. 80% of the blood supply entering the human liver arrives from the splanchnic circulation through the portal vein, so it is constantly exposed to immunologically active substances and pathogens from the gastrointestinal tract. Rapid neutralization of pathogens and toxins is an essential function of the liver, but so too is avoidance of harmful and unnecessary immune reactions. This delicate balance of reactivity and tolerance is orchestrated by a diverse repertoire of hepatic immune cells. In particular, the human liver is enriched in many innate immune cell subsets, including Kupffer cells (KCs), innate lymphoid cells (ILCs) like Natural Killer (NK) cells and ILC-like unconventional T cells - namely Natural Killer T cells (NKT), γδ T cells and Mucosal-associated Invariant T cells (MAIT). These cells reside in the liver in a memory-effector state, so they respond quickly to trigger appropriate responses. The contribution of aberrant innate immunity to inflammatory liver diseases is now being better understood. In particular, we are beginning to understand how specific innate immune subsets trigger chronic liver inflammation, which ultimately results in hepatic fibrosis. In this review, we consider the roles of specific innate immune cell subsets in early inflammation in human liver disease.
Keywords: Gd T cell; Hepatitis (general); Inflammation; Innate immnuity; MAIT cell; NK cells; NKT (natural killer T) cell; kupffer cell (KC).
Copyright © 2023 Yang Zhou.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.Front Immunol. 2018 Sep 21;9:1990. doi: 10.3389/fimmu.2018.01990. eCollection 2018. Front Immunol. 2018. PMID: 30298063 Free PMC article. Review.
-
The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.Front Immunol. 2019 Jul 11;10:1597. doi: 10.3389/fimmu.2019.01597. eCollection 2019. Front Immunol. 2019. PMID: 31354734 Free PMC article. Review.
-
Control of the Development, Distribution, and Function of Innate-Like Lymphocytes and Innate Lymphoid Cells by the Tissue Microenvironment.Adv Exp Med Biol. 2024;1444:111-127. doi: 10.1007/978-981-99-9781-7_8. Adv Exp Med Biol. 2024. PMID: 38467976 Review.
-
T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease.Int J Mol Sci. 2021 Nov 11;22(22):12190. doi: 10.3390/ijms222212190. Int J Mol Sci. 2021. PMID: 34830072 Free PMC article. Review.
-
Immunity, tolerance and autoimmunity in the liver: A comprehensive review.J Autoimmun. 2016 Jan;66:60-75. doi: 10.1016/j.jaut.2015.08.020. Epub 2015 Sep 7. J Autoimmun. 2016. PMID: 26358406 Review.
Cited by
-
CCR2+TREM-1+ monocytes promote natural killer T cell dysfunction contributing towards HBV disease progression.Immunol Res. 2024 Oct;72(5):938-947. doi: 10.1007/s12026-024-09495-4. Epub 2024 May 30. Immunol Res. 2024. PMID: 38814567
-
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease.Biomedicines. 2024 Jan 27;12(2):299. doi: 10.3390/biomedicines12020299. Biomedicines. 2024. PMID: 38397901 Free PMC article. Review.
-
Purinergic Signaling in Non-Parenchymal Liver Cells.Int J Mol Sci. 2024 Aug 30;25(17):9447. doi: 10.3390/ijms25179447. Int J Mol Sci. 2024. PMID: 39273394 Free PMC article. Review.
-
Vaccination with O-linked Mannans Protects against Systemic Candidiasis through Innate Lymphocyte Populations.J Immunol. 2024 Sep 15;213(6):843-852. doi: 10.4049/jimmunol.2400065. J Immunol. 2024. PMID: 39109925
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical